These Stocks Can Make or Break Investors (Most Don't Understand How It Works)

Podcast: MarketBeat | Stock Market News & Analysis · MarketBeat

Opublikowano: 2026-10-14

Read the Full Report on Quantum BioPharma: https://www.marketbeat.com/y/yt1015/ Quantum BioPharma's Anthony Durkacz joins MarketBeat's Bridget Bennett to break down the FDA approval process and what investors need to know before buying biotech stocks. AI is speeding up drug discovery, but every drug still has to get through the same hoops, and most never make it. In this interview, you'll hear what happens in phase 1, phase 2, and phase 3 clinical trials, why Anthony says most of the value tends to build after phase 2 data, when big pharma usually steps in, and how funding...